A one‑year course of T‑DM1 offers excellent cancer‑free survival for early HER2‑positive breast cancer, with far less nerve damage and hair loss than standard chemotherapy.

A fleeting DNA fold called i‑DNA can switch cancer‑related genes on and off, revealing a hidden structural weak point that future therapies might exploit to collapse tumors.

Hot-mixed Roman concrete used quicklime “healing” clasts that seal cracks over time, explaining Pompeii’s long‑lasting structures and inspiring tougher, lower‑carbon concretes today.

CRISPR gene therapy Casgevy can nearly eliminate sickle cell crises, but difficult stem‑cell collection is delaying access and exposing fragile gene‑therapy infrastructure.

A new study from Harvard University finds that people who live closer to nuclear power plants have a higher risk of dying from cancer than those further away.

New findings that snakes thrive without the hunger hormone ghrelin suggest future obesity drugs could safely mute hunger at its source, complementing today’s satiety‑boosting therapies.

Fast functional testing of genetic variants, from newborn genomes to disease models like zebrafish, is transforming ambiguous DNA findings into confident, real‑time treatment decisions.

Senators Hawley and Warren want to break up vertically integrated healthcare conglomerates. History shows, however, how hard a task this will be to accomplish.

It’s conspicuous that HHS refuses to review Moderna’s application for regulatory approval of an mRNA-based flu vaccine while it prioritizes research on debunked theories.

Tobacco smoking, alcohol consumption and infections were the three leading causes of preventable cancers according to research by the World Health Organization.